GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Operating Margin %

Abaxis (Abaxis) Operating Margin % : 17.94% (As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Abaxis's Operating Income for the three months ended in Mar. 2018 was $12.2 Mil. Abaxis's Revenue for the three months ended in Mar. 2018 was $67.9 Mil. Therefore, Abaxis's Operating Margin % for the quarter that ended in Mar. 2018 was 17.94%.

The historical rank and industry rank for Abaxis's Operating Margin % or its related term are showing as below:


ABAX's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -5.15
* Ranked among companies with meaningful Operating Margin % only.

Abaxis's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Abaxis's Operating Income for the three months ended in Mar. 2018 was $12.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2018 was $38.7 Mil.


Abaxis Operating Margin % Historical Data

The historical data trend for Abaxis's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Operating Margin % Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.95 16.93 21.18 19.58 15.80

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.18 14.52 16.03 14.37 17.94

Competitive Comparison of Abaxis's Operating Margin %

For the Diagnostics & Research subindustry, Abaxis's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Abaxis's Operating Margin % falls into.



Abaxis Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Abaxis's Operating Margin % for the fiscal year that ended in Mar. 2018 is calculated as

Operating Margin %=Operating Income (A: Mar. 2018 ) / Revenue (A: Mar. 2018 )
=38.655 / 244.7
=15.80 %

Abaxis's Operating Margin % for the quarter that ended in Mar. 2018 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2018 ) / Revenue (Q: Mar. 2018 )
=12.182 / 67.918
=17.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abaxis  (NAS:ABAX) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Abaxis Operating Margin % Related Terms

Thank you for viewing the detailed overview of Abaxis's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020